COGNICURRENT

Feb 4 • 14:44 UTC • 🌍 Africa • AllAfrica

South Africa: Blockbuster Weight-Loss and Diabetes Medicines Sales Surge Despite Cost Barriers

Sales of glucagon-like peptide-1 receptor agonists for weight loss and diabetes have surged in South Africa, yet accessibility remains limited due to high costs.

#south africa #weight loss #diabetes #healthcare #cost barriers

Read Original Back to Feed

📡 Similar Coverage

🇧🇷 Brazil Feb 16 • 02:00 UTC

Weight loss pens expected to account for 20% of pharmacy revenue by 2030

Folha (PT)

🇩🇪 Germany Feb 18 • 12:38 UTC

Industry suffers: Weight loss injections cause a drop in sugar prices

FAZ

🇬🇷 Greece Feb 25 • 11:21 UTC

Novo Nordisk: Reducing drug prices for obesity and diabetes by 50% in the USA

Naftemporiki

🇩🇪 Germany Feb 4 • 17:12 UTC

Weight Loss Injections: Novo Nordisk Predicts "Shocking" Sales Decline

FAZ

🇧🇷 Brazil Feb 12 • 16:45 UTC

Weight loss injections drop sugar prices to the lowest level in five years

Folha (PT)

🇧🇷 Brazil Feb 18 • 15:00 UTC

You achieved your weight loss goal with GLP-1 pens, and now?

Folha (PT)